Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07401290 · ClinicalTrials.gov registry record · NA
The Safety and Efficacy of Direct SLT in Pseudoexfoliation Glaucoma
A NA study, sponsored by Vance Thompson Vision.
- Not yet
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07401290 is a NA study that has not yet begun recruiting, run by Vance Thompson Vision. The registered enrollment target is 40 participants.
The verdict
NCT07401290, a NA study, has not yet begun recruiting, sponsored by Vance Thompson Vision.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Prospective, multi-center, single arm, interventional study evaluating DSLT in patients with pseudoexfoliative glaucoma.
Interventions
- DEVICE Direct selective laser trabeculoplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-03 |
| Est. Completion | 2028-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07401290
The ClinicalTrials.gov registry entry for NCT07401290 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vance Thompson Vision, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Direct selective laser trabeculoplasty is the first listed.
NCT07401290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07401290 about?
NCT07401290 is a clinical study titled "The Safety and Efficacy of Direct SLT in Pseudoexfoliation Glaucoma". Prospective, multi-center, single arm, interventional study evaluating DSLT in patients with pseudoexfoliative glaucoma.
What is the current status of trial NCT07401290?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-03. Estimated completion is 2028-03.
What interventions are being tested in trial NCT07401290?
The interventions under investigation include: Direct selective laser trabeculoplasty (DEVICE).
Who is sponsoring clinical trial NCT07401290?
This trial is sponsored by Vance Thompson Vision, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.